Back to Article List

Monacolins from red yeast rice

European Union

Jun 13, 2022

Commission Regulation (EU) 2022/860 of 1 June 2022 amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards monacolins from red yeast-fermented rice has been published.

Annex III to Regulation (EC) No 1925/2006 is amended as follows:

Restricted substance

Conditions of use

Additional requirements

‘Monacolins from red yeast rice

Individual portion of the product for daily consumption

shall provide less than 3 mg of monacolins from red yeast rice.

The label shall provide the number of individual portions of the product for maximum daily consumption and a

warning not to consume a daily amount of 3 mg of monacolins from red yeast rice or more.

The label shall indicate the content of monacolins per portion of the product.

The label shall include the following warnings:

“Should not be consumed by pregnant or lactating women, children below 18 years old and adults above 70 years old”.

“Seek advice from a doctor on consumption of this product if you experience any health problems”;

“Should not be consumed if you are taking cholesterol-lowering medication”;

“Should not be consumed if you are already consuming other products containing red yeast rice”.’


For further information (in English), click on the Link

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox